Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2020

Jun 19, 2020

35106_dirs_2020-06-19_2b331a14-4ea8-4c3c-a65d-19946a12cce5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2020-06-17

Reporting Person: Schwartz Carl I. (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-17 Common Stock A 4070 Acquired 1611981 Direct

Footnotes

F1: Director stock grant.